Shafali Spurling Jeste, M.D.

Shafali Spurling Jeste, M.D.

Associate Professor in Psychiatry, Pediatrics and Neurology
Director, Care and Research in Neurogenetics Clinic (CARING Clinic)
David Geffen School of Medicine at UCLA

Dr. Shafali Jeste is Associate Professor in Psychiatry, Pediatrics and Neurology at the David Geffen School of Medicine at UCLA. She is a behavioral child neurologist specializing in autism and related neurodevelopmental disorders. Dr. Jeste’s research is focused on the use of novel electrophysiological biomarkers to better define early predictors of autism spectrum disorder (ASD) and to define more homogeneous, brain-based subgroups within the autism spectrum in order to inform treatment targets. She has designed innovative studies in early predictors of ASD to focus on the integration of biomarkers with behavior to define atypical development prior to the onset of clinical symptoms. Within this framework, she has been investigating and treating infants and children with neurogenetic syndromes associated with ASD. She is the principal investigator of several studies, including early development and intervention for infants with tuberous sclerosis complex and the UCLA Autism Center of Excellence study of high-risk infant siblings. Dr. Jeste serves as the UCLA site director for a multisite National Institutes of Health Autism Biomarkers Consortium for Clinical Trials research study. Clinically, she evaluates and treats patients with ASD and neurological comorbidities, and directs the UCLA Care and Research in Neurogenetics Clinic (CARING Clinic). Dr. Jeste has published more than 50 peer-reviewed articles and has been the recipient of the Child Neurology Foundation’s Researcher-in-Training Award and the American Academy of Neurology’s Clinical Researcher-in- Training Award. She serves on the board of directors for the Child Neurology Foundation and was elected to serve on the board of directors for the International Society for Autism Research.